SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000908834-24-000055
Filing Date
2024-02-13
Accepted
2024-02-13 15:40:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 acrv_13ga.htm SC 13G/A 64984
  Complete submission text file 0000908834-24-000055.txt   66488
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Subject) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93824 | Film No.: 24625332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209
Business Address 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
Sands Capital Ventures, LLC (Filed by) CIK: 0001846444 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A